El Vínculo El Vínculo.
Direct award European Union Supplies

Arzneimittelbezeichnung: Glecaprevir und Pibrentasvir - Maviret Wirkstoff: Bimekizumab ATC-Code: L04AC21

Buyer: AOK Bayern - Die Gesundheitskasse

Published
13 November 2024
Place of performance
DE212
Procedure
Negotiated procedure
Lots
1
Notice number
00689979-2024
Reference
f77c7100-24a3-486e-993c-8c4c4054fb42
Official source
Official source

CPV codes

Description

Arzneimittelbezeichnung: Glecaprevir und Pibrentasvir - Maviret Wirkstoff: Bimekizumab ATC-Code: L04AC21

Awards

Awarded toAmountDate
Novartis Pharma GmbH

Official publications

Other tenders from AOK Bayern - Die Gesundheitskasse

Frequently asked questions

Who is the buyer of this tender?
The contracting authority is AOK Bayern - Die Gesundheitskasse (European Union).
How can I bid for public tenders in European Union?
Bids are submitted through the official procurement portal of European Union. El Vínculo helps you find tenders and analyse their documents; submission always happens at the official source.
Get alerts for tenders like this
Create a free account and receive new tenders from European Union matching your business, every day.

Start for free

Data collected from official public procurement sources. Amounts as published by the buyer.